Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants With Presbyopia
Conditions
Interventions
Pilocarpine HCl Ophthalmic Solution
Vehicle
Locations
35
United States
Eye Center South
Dothan, Alabama, United States
M&M Eye Institute
Prescott, Arizona, United States
Walman Eye Center
Sun City, Arizona, United States
Milton M. Hom, OD, FAAO
Azusa, California, United States
Global Research Management
Glendale, California, United States
Advanced Vision Care
Los Angeles, California, United States
Start Date
March 1, 2019
Primary Completion Date
September 10, 2020
Completion Date
September 10, 2020
Last Updated
December 29, 2021
NCT07444658
NCT06060041
NCT07232615
NCT03135327
NCT07051720
NCT06948357
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions